We demonstrated here that targeted inhibition of mTOR significantly enhanced the generation and maintenance of CD133+ subpopulations and promoted secondary tumor re-propagation of H-Ras-transformed mouse liver tumor cells in vivo. This evidence concerns the gene HRAS and neoplasm.